1. Drug evaluation: the directly activated Factor Xa inhibitor otamixaban;Nutescu;IDrugs,2006
2. The discovery of the Factor Xa inhibitor otamixaban: from lead identification to clinical development;Guertin;Curr Med Chem,2007
3. Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure;Paccaly;J Clin Pharmacol,2006
4. Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor;Paccaly;Thromb Haemost,2005
5. Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial;Cohen;Circulation,2007